The latest edition of Meds Pipeline Monitor, from the Patented Medicine Prices Review Board, provides stakeholders with a list of new medicines in the late stages of clinical evaluation that may ...
Significantly increasing number of feasibility studies and data release approvals from expected EHDS legislation in force from 2025 to full implementation in 2028 to be supported by Platform BC ...